-+ 0.00%
-+ 0.00%
-+ 0.00%

Bernstein Maintains Market Perform on Regeneron Pharmaceuticals, Raises Price Target to $812

Benzinga·11/02/2026 18:42:08
Bernstein analyst Jeffrey Walch maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Market Perform and raises the price target from $756 to $812.